RE: RE: PRX 5-STAR RATINGBioboy: While I also would like to see your preferred option, I disagree that PRX needs big pharma for P3. I expect that the results from P2a will be positive and consistent with earlier open label.
Based on that assessment, P3 likely will be an expansion of P2b...a larger sample size measuring the same result popints: prostate volume, urine flow, QoL and side effects/adverse reactions.